Robot arm aims to steady heart valve implants

NCT ID NCT07152574

Not yet recruiting Disease control Sponsor: Caranx Medical Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This early study tests a tele-operated robot called TAVIPILOT that helps doctors position a new heart valve during a minimally invasive procedure called TAVR. Ten patients aged 65 and older with severe aortic stenosis will take part. The main goals are to see if the robot is safe and easy for doctors to use.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: TAVIPILOT tele-operated robot (device)
What this could lead to: If successful, this robot could make heart valve replacement more precise and consistent, potentially improving outcomes for patients with severe aortic stenosis.
What could go wrong: This is a very early feasibility study with only 10 patients. The robot may not improve results or could have technical issues. It is not yet proven safe or effective.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AORTIC STENOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

aortic valve stenosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TAVI(TRANSCATHETER AORTIC VALVE IMPLANTATION)

More trials for these conditions

Other studies related to the condition(s) this trial covers.